1. Home
  2. Faculty

Scott K. Sherman, MD

Clinical Assistant Professor of Surgery - Surgical Oncology and Endocrine Surgery

Current Positions

  • Clinical Assistant Professor of Surgery - Surgical Oncology and Endocrine Surgery
  • Staff Physician, Veterans Affairs Medical Center, Iowa City, Iowa

Education

  • A.B. in Molecular Biology, Princeton University, Princeton, New Jersey
  • Complex General Surgical Oncology Fellowship in Surgical Oncology, University of Chicago, Chicago, Illinois
  • M.D., University of Chicago Pritzker School of Medicine, Chicago, Illinois
  • Research Fellow, University of Iowa Carver College of Medicine, Iowa City, Iowa
  • Administrative Chief Resident in General Surgery, University of Iowa Hospitals & Clinics, Iowa City, Iowa

Selected Publications

  • Borbon, L.C., Sherman, S.K., Breheny, P.J. et al. (2024) Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors. Ann Surg Oncol (2024). doi.org/10.1245/s10434-024-16463-7
  • D’Angelica, M.I. et al. (2023). Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy: A randomized clinical trial. JAMA. 2023 May 9;329(18):1579-88. Doi: 10.1001/jama.2023.5728.
  • Su Y, Chang J, Sherman SK, De Andrade JP, Hoshi H, Howe JR, Chan CHF. Relationship of biliary fungal contamination with pancreatectomy postoperative complications. Presented at Academic Surgical Congress (2024).
  • Suraju MO, Su Y, Chang J, Katwala A, Nayyar A, Gordon DM, Sherman SK, Hoshi H, Chan CHF. Irreversible electroporation as a potential adjunct for locally advanced pancreatic cancer. Abstract submitted to Society of Surgical Oncology Advanced Cancer Therapies Meeting (2024).
  • Borbon LC, Sherman SK, Breheny P, Ear PH, Menda Y, Chandrasekharan C, Bellizzi AM, O’Dorisio TM, Dillon JS, Howe JR. “Peptide receptor radionuclide therapy improves progression free and overall survival in patients who progress after resection of gastroenteropancreatic neuroendocrine tumors. Submitted to European Neuroendocrine Tumor Society meeting (2024).
  • Tran CG, Armstrong-Pavlik FA, Suraju MO, Chang J, Nayyar A, Cromwell JW, Nau P, De Andrade J, Sherman SK. Using artificial intelligence to improve voice recognition in surgery. Oral presentation of abstract by Ms. Armstrong-Pavlik at American College of Surgeons Clinical Congress Scientific Forum (2023).
  • Tran CG, Sherman SK, De Andrade JP. Performance of ChatGPT on the American Board of Surgery Inservice Training Exam (ABSITE) Preparation Questions. Presented by Dr. Tran at the Society of Asian Academic Surgeons meeting (2023).
  • Chang J, Fei N, Chandrasekharan C, Sherman SK, De Andrade JP, Howe JR, Hoshi H, Chan CHF. “Clinical impact of tumor mutational profiling in resected pancreas cancer: A single institution experience.” Abstract submitted to SSO (2023).
  • Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O’Dorisio TM, Howe JR. Is there a role for surgical resection of grade 3 neuroendocrine neoplasms? Poster presented by Dr. Borbon at NANETs Multidisciplinary NET Symposium (2022).
  • Tran GC, Scott AT, Li G, Sherman SK, Ear PH, Howe JR. Metastatic pancreatic neuroendocrine tumors have decreased somatostatin expression and increased Akt signaling. Abstract presented by Dr. Tran at American Association of Endocrine Surgeons Meeting (2021).